Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -1.283\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a Cc1cccc(C(=O)N(Cc2nc3ccccc3c(=O)[nH]2)C2CCCC2)c1
b CCOC(=O)C1(CCc2ccccc2)CCN(Cc2ccn[nH]2)CC1
c COc1ccc(NC(=O)CC2Nc3cccc4cccc(c34)NC2=O)cc1
Answer: c. COc1ccc(NC(=O)CC2Nc3cccc4cccc(c34)NC2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=O)CC2Nc3cccc4cccc(c34)NC2=O)cc1
COc1ccc(NC(=O)CC2Nc3cccc4cccc(c34)NC2=O)cc1
N-(4-methoxyphenyl)-2-(12-oxo-10,13-diazatricyclo[7.4.1.05,14]tetradeca-1,3,5(14),6,8-pentaen-11-yl)acetamide